title: [Prognostic evaluation of prostatic cancer by Gleason's histopathologic grading and tissue DHT level].
authors.forename: Y
authors.initials: Y
authors.lastname: Kohama
authors.forename: M
authors.initials: M
authors.lastname: Morioka
authors.forename: Y
authors.initials: Y
authors.lastname: Kamei
authors.forename: Y
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Sen
authors.forename: Y
authors.initials: Y
authors.lastname: Fujita
authors.forename: H
authors.initials: H
authors.lastname: Sonobe
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000031:analogs & derivatives / Q000627:therapeutic use; D013196:Dihydrotestosterone / Q000032:analysis*; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000032:analysis / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D013196:Dihydrotestosterone; D004054:Diethylstilbestrol; C004955:fosfestrol; D008525:Medroxyprogesterone